Share →

Johnson & Johnson, one of the world’s largest health-care conglomerates, nurtures a family-friendly image as it sells Band-Aids and baby shampoo, soaps and skin creams.

“We are responsible to the communities in which we live and work and to the world community as well,” reads a sentence in the company credo, written in 1943 by Robert Wood Johnson, a member of the company’s founding family.

But, by connecting it to an epidemic that has ravaged the country for two decades, Oklahoma’s attorney general plans to expose another side of the company when the first major state trial of the opioid era begins later this month.

In a trial that will be televised live, state lawyers will argue that, until 2016, two of the company’s subsidiaries grew, improved and provided the narcotic ingredients for much of the U.S. prescription opioid supply, failing to intervene as the drugs’ damage grew.

Source: Spotlight shifts to Johnson & Johnson as first major opioid trial nears in Oklahoma | National | unionleader.com